Most Popular Products
China Retatrutide manufacturer
4.0 USD ($)/Vial
Product Details:
- Shelf Life 18 Months
- Smell No Smell
- Taste Odorless
- HS Code 2937190099
- Solubility Soluble in Bacteriostatic water
- Molecular Weight 4731.33 Drams (dr)
- Click to View more
X
China Retatrutide manufacturer Price And Quantity
- 1 Vial
- 4.0 USD ($)/Vial
China Retatrutide manufacturer Product Specifications
- 4731.33 Drams (dr)
- Soluble in Bacteriostatic water
- Pharmaceutical Intermediates
- 2937190099
- Retatrutide is primarily used to aid weight loss (for the treatment of obesity) and to improve glycemic control in patients with type 2 diabetes. Key Uses and Benefits: Potent Weight Loss: By simultaneously activating glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCGR) receptors, it effectively suppresses appetite, delays gastric emptying, and enhances the body's fat-burning capacity. Clinical trials have demonstrated significant weight loss, with some participants achieving an average weight reduction of 24% or more. Blood Glucose Control: It promotes insulin secretion in a glucose-dependent manner, helping patients with type 2 diabetes improve their overall metabolic health and blood glucose levels.
- Retatrutide
- C221H342N46O68
- Retatrutide
- Freezer
- 7.0%
- Powder
- No Smell
- Medicine Grade
- 18 Months
- 2381089-83-2
- 99.00%
- Odorless
- White powder
China Retatrutide manufacturer Trade Information
- Shenzhen or Guangzhou
- Telegraphic Transfer (T/T)
- 100000 Vial Per Week
- 5 Days
- Yes
- Free samples available with shipping and taxes paid by the buyer
- 10 vials per kit
- Australia, North America, Western Europe, Middle East
- GMP, ISO
Product Description
Retatrutide is an investigational injectable peptide drug developed by Eli Lilly, it belongs to a new generation of triple hormone receptor agonists.
Basic mechanism of action:
* Triple targeting: It simultaneously activates three receptorsthe glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR).
* Synergistic effect: Compared to traditional drugs that target only a single receptor (such as semaglutide) or dual receptors (such as tirzepatide), the addition of glucagon receptor activation can further increase energy expenditure and promote hepatic fat breakdown.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'APIs And Intermediates' category
![]() |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |




